Posting of Annual Report and

RNS Number : 9751K
Surgical Innovations Group PLC
28 April 2010



Press Release

28 April 2010



Surgical Innovations Group plc


("SI" or "the Group")


Appointment of Graham Bowland as Chief Executive Officer


 Posting of Annual Report and Accounts and AGM Notice



Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative medical devices, is pleased to announce that Graham Bowland, previously Group Finance Director, has been appointed to the role of Group Chief Executive Officer with immediate effect. 


SI also announces that its Annual Report and Accounts for the year ended 31 December 2009 will be sent to shareholders on 30 April 2010.  Electronic copies are available for download at, the investor relations section of the Group's website.


The Group also gives notice that its Annual General Meeting will be held at 1.00 pm on 25 May 2010 at Clayton Wood House, 6 Clayton Wood Bank, Leeds LS16 6QZ.


- Ends -


For further information:

Surgical Innovations Group plc

Doug Liversidge, Non-Executive Chairman

Tel: +44 (0) 113 230 7597

Graham Bowland, Chief Executive Officer

Tel: +44 (0) 113 230 7597


Westhouse Securities Limited

Tim Feather / Matthew Johnson

Tel: +44 (0) 113 246 2611




Media enquiries:

Abchurch Communications

Sarah Hollins / Simone Elviss / Quincy Allan

Tel: +44 (0) 20 7398 7728


Notes to Editors:


About Surgical Innovations Group plc

Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery and industrial markets.  The Group has two divisions; Surgical Innovations Limited and Haemocell Limited.


The Group employs over 90 people at its 32,000 square feet facility in Leeds, with in-house design and the manufacturing of products to the highest quality standards.  Through an established network of 45 distribution partners, SI sells in all major medical markets including North America, Europe, South Africa, the Middle East, South-East Asia and Australia.


Surgical Innovations Limited, the main trading subsidiary of the Group, is focused on developing medical instruments for the laparoscopic surgery market - minimally invasive surgery of the abdomen.  The Group has pioneered Resposable® instrumentation combining both single use and reusable components ensuring an ongoing revenue stream and delivering the optimum procedure performance to cost ratio.  The Group's products include:



A resposable® laparoscopic port access system that combines both single-use and reusable components


resposable® laparoscopic instrumentation that combines both single-use and reusable components


single-use instruments, with an ergonomic handle to ensure accurate control of the instrument. The range includes scissors, graspers and dissectors


In addition to its own branded instruments, the Group also designs and manufactures devices on an OEM basis for large medical device companies including Teleflex Medical, Gyrus, Olympus and Cardinal Health.


For more information, see




This information is provided by RNS
The company news service from the London Stock Exchange
UK 100

Latest directors dealings